Orally Disintegrating Tablet (ODT) Market Analysis, Size, Current Scenario and Future Prospects

Orally disintegrating tablet (ODT) market is anticipated to grow at a significant CAGR during the forecast period. According to the US Food and Drug Administration (FDA), ODT's are a solid dosage form that contains a medicinal substance or active ingredient which rapidly disintegrates when placed upon the tongue within a second. The major factor for the growth of the global orally disintegrating tablet (ODT) market during the forecast period is the increasing demand for these tablets due to ease of use and new product launches.

For instance, in February 2022, Dr Reddy's Laboratories Ltd. along with its subsidiaries announced the launch of Lansoprazole DR Orally Disintegrating Tablets. These tablets are a therapeutic equivalent generic version of Prevacid SoluTab delayed-release orally disintegrating tablets, 15 mg and 30 mg, which is approved by the US FDA. Additionally, in July 2021, SPI Pharma launched UltraBurst an orally disintegrating tablet (ODT). Ultrabrust is an innovative excipient platform for flash ODTs, which disintegrate in under ten seconds. Furthermore, in December 2021, Edenbridge Pharmaceuticals, LLC announced the approval of its New Drug Application (NDA) for DARTISLA ODT (glycopyrrolate) orally disintegrating tablets from the US FDA. DARTISLA ODT is an orally disintegrating tablet available in 1.7 mg for the treatment of peptic ulcers in adults.

Some major players in the market include Teva Pharmaceutical Industries Ltd., Merck KGaA, and Mylan N.V., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in November 2021, Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced a strategic commercialization arrangement for rimegepant in markets outside of the US. Rimegepant is commercialized as Nurtec ODT in the US and is used for the treatment of episodic migraine in adults.

To Request a Sample of our Report on Orally Disintegrating Tablet (ODT) Market: https://www.omrglobal.com/request-sample/orally-disintegrating-tablet-odt-market

Market Coverage

• The market number available for - 2022-2030

• Base year- 2022

• Forecast period- 2022-2030

• Segment Covered-

· By Drug Class

· By Disease Indication

· By Distribution Channel

• Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

• Competitive Landscape- Teva Pharmaceutical Industries Ltd., Merck KGaA, and Mylan N.V., among others.

A full Report Orally Disintegrating Tablet (ODT) Market is Available @ https://www.omrglobal.com/industry-reports/orally-disintegrating-tablet-odt-market

Orally Disintegrating Tablet (ODT) Market Report by Segment

By Drug Class

• Anti-Psychotics

• Anti-Epileptics

• CNS Stimulants

• Anxiolytics

• Anti-Parkinsonian Drugs

• NSAIDS

• Anti-Allergy Drugs

• Others

By Disease Indication

• CNS Diseases

• GI Diseases

• CVS Disorders

• Allergy

• Others

By Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Drug Stores

• Online Pharmacies

Orally Disintegrating Tablet (ODT) Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.